Jeffrey H. Burbank, Chief Executive Officer at NxStage Medical, Inc. (NXTM), sold 7,500 shares at $27.63 ($207K) on 2017-01-18, disclosed to the SEC on 2017-01-18.
Seasonal sale ($207k) by Chief Executive Officer — this insider has traded NXTM in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| NXTM | SELL | 2017-03-23 | $82K | — | Filing → |
| NXTM | SELL | 2017-03-22 | $83K | — | Filing → |
| NXTM | SELL | 2017-02-24 | $217K | — | Filing → |